Penn Center for Innovation

Philadelphia biotech company expands successful partnership with Penn

Posted on May 31, 2020 — Jessica Jones Gupta

Cabaletta Bio is expanding its sponsored research agreement with Penn to include three additional B cell-mediated autoimmune disease targets.

The research will be conducted under the direction of Cabaletta co-founder Dr. Aimee Payne, an associate professor of dermatology in Penn’s Perelman School of Medicine and director of the Penn Clinical Autoimmunity Center of Excellence.

Read More on the Philadelphia Business Journal

Category: external, news